全文获取类型
收费全文 | 131811篇 |
免费 | 44972篇 |
国内免费 | 628篇 |
专业分类
耳鼻咽喉 | 2531篇 |
儿科学 | 5588篇 |
妇产科学 | 1456篇 |
基础医学 | 24853篇 |
口腔科学 | 7660篇 |
临床医学 | 15920篇 |
内科学 | 28864篇 |
皮肤病学 | 4501篇 |
神经病学 | 19021篇 |
特种医学 | 6246篇 |
外国民族医学 | 6篇 |
外科学 | 21647篇 |
综合类 | 2104篇 |
现状与发展 | 1篇 |
一般理论 | 12篇 |
预防医学 | 9825篇 |
眼科学 | 1541篇 |
药学 | 10280篇 |
28篇 | |
中国医学 | 1870篇 |
肿瘤学 | 13457篇 |
出版年
2024年 | 63篇 |
2023年 | 740篇 |
2022年 | 853篇 |
2021年 | 2912篇 |
2020年 | 7182篇 |
2019年 | 12582篇 |
2018年 | 12145篇 |
2017年 | 13193篇 |
2016年 | 12202篇 |
2015年 | 12022篇 |
2014年 | 12357篇 |
2013年 | 12785篇 |
2012年 | 11189篇 |
2011年 | 11265篇 |
2010年 | 9770篇 |
2009年 | 6345篇 |
2008年 | 6830篇 |
2007年 | 5211篇 |
2006年 | 4896篇 |
2005年 | 4581篇 |
2004年 | 4300篇 |
2003年 | 3986篇 |
2002年 | 3732篇 |
2001年 | 2882篇 |
2000年 | 1637篇 |
1999年 | 461篇 |
1998年 | 235篇 |
1997年 | 210篇 |
1996年 | 147篇 |
1995年 | 115篇 |
1994年 | 99篇 |
1993年 | 64篇 |
1992年 | 53篇 |
1991年 | 44篇 |
1990年 | 40篇 |
1989年 | 30篇 |
1988年 | 20篇 |
1987年 | 36篇 |
1986年 | 32篇 |
1985年 | 33篇 |
1984年 | 27篇 |
1983年 | 13篇 |
1982年 | 27篇 |
1981年 | 15篇 |
1980年 | 9篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1977年 | 11篇 |
1976年 | 9篇 |
1975年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Anela Stanic Denis Rybin Francis Cannata Carole Hohl Jennifer Brody Jessie Gaeta 《AIDS care》2021,33(1):1-9
ABSTRACT The lack of stable housing can impair access and continuity of care for patients living with human immunodeficiency virus (HIV). This study investigated the relationship between housing status assessed at multiple time points and several core HIV-related outcomes within the same group of HIV patients experiencing homelessness. Patients with consistently stable housing (CSH) during the year were compared to patients who lacked CSH (non-CSH group). The study outcomes included HIV viral load (VL), CD4 counts, and health care utilization. Multivariable and propensity weighted analyses were used to assess outcomes adjusting for potential group differences. Of 208 patients, 88 (42%) had CSH and 120 (58%) were non-CSH. Patients with CSH had significantly higher proportion of VL suppression and higher mean CD4 counts. The frequency of nurse visits in the CSH group was less than a half of that in the non-CSH group. Patients with CSH were less likely to be admitted to the medical respite facility, and if admitted, their length of stay was about a half of that for the non-CSH group. Our study findings show that patients with CSH had significantly better HIV virologic control and immune status as well as improved health care utilization. 相似文献
5.
6.
Phoebe Hammer Kevin White Stephanie Mengden Vessy Korcheva Philipp W. Raess 《Journal of cutaneous pathology》2019,46(5):343-346
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances. 相似文献
7.
Keiko Goto Yutaka Fujiwara Takeshi Isobe Naoko Chayahara Naomi Kiyota Toru Mukohara Yukari Tsubata Takamasa Hotta Kenji Tamura Noboru Yamamoto Hironobu Minami 《Cancer science》2019,110(6):1987-1994
Although dose reduction of S‐1 is recommended for patients with impaired renal function, dose modification for such patients has not been prospectively evaluated. The aim of the present study was to investigate the pharmacokinetic parameters of 5‐fluorouracil, 5‐chloro‐2,4 dihydroxypyridine and oteracil potassium, and to review the recommended dose modification of S‐1 in patients with renal impairment. We classified patients receiving S‐1 into 4 groups according to their renal function, as measured using the Japanese estimated glomerular filtration rate (eGFR) equation. The daily S‐1 dose was adjusted based on the patient's eGFR and body surface area. Blood samples were collected for pharmacokinetic analysis. A total of 33 patients were enrolled and classified into 4 groups as follows: 10 patients in cohort 1 (eGFR ≥ 80 mL/min/1.73 m2), 10 patients in cohort 2 (eGFR = 50‐79 mL/min/1.73 m2), 10 patients in cohort 3 (eGFR = 30‐49 mL/min/1.73 m2), and 3 patients in cohort 4 (eGFR < 30 mL/min/1.73 m2). Those in cohorts 3 and 4 treated with an adjusted dose of S‐1 showed a similar area under the curve for 5‐fluorouracil (941.9 ± 275.6 and 1043.5 ± 224.8 ng/mL, respectively) compared with cohort 2 (1034.9 ± 414.3 ng/mL). Notably, while there was a statistically significant difference between cohort 1 (689.6 ± 208.8 ng/mL) and 2 (P = 0.0474) treated with an equal dose of S‐1, there was no significant difference observed in the toxicity profiles of the cohorts. In conclusion, dose adjustment of S‐1 in patients with impaired renal function using eGFR is appropriate and safe. 相似文献
8.
9.